EUR 575.6
(1.34%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 281.12 Million EUR | 23.11% |
2022 | 228.35 Million USD | 109.35% |
2021 | 109.07 Million USD | 331.93% |
2020 | 25.25 Million EUR | 2229.23% |
2019 | 1.08 Million EUR | 101054018719188.89% |
2018 | - EUR | -100.0% |
2017 | 2.00 EUR | 200324867.16% |
2016 | - EUR | -100.0% |
2015 | 1.00 EUR | -100.0% |
2014 | 111.87 Thousand EUR | -23.57% |
2013 | 146.37 Thousand EUR | 30.21% |
2012 | 112.41 Thousand EUR | 70.07% |
2011 | 66.1 Thousand EUR | 10424550.74% |
2010 | 0.63 EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - USD | -100.0% |
2024 Q2 | 326.46 Million EUR | 0.0% |
2023 Q3 | - USD | -100.0% |
2023 Q1 | - USD | -100.0% |
2023 Q2 | 201.11 Million USD | 0.0% |
2023 FY | 281.12 Million EUR | 23.11% |
2023 Q4 | 310.55 Million USD | 0.0% |
2022 Q3 | - USD | -100.0% |
2022 FY | 228.35 Million USD | 109.35% |
2022 Q2 | 135.71 Million USD | 0.0% |
2022 Q4 | 228.35 Million USD | 0.0% |
2021 Q4 | 109.07 Million USD | 0.0% |
2021 FY | 109.07 Million USD | 331.93% |
2021 Q2 | 59.21 Million USD | 0.0% |
2020 Q4 | 25.25 Million EUR | 0.0% |
2020 Q2 | 5.59 Million EUR | 0.0% |
2020 FY | 25.25 Million EUR | 2229.23% |
2019 FY | 1.08 Million EUR | 101054018719188.89% |
2019 Q2 | 1.00 EUR | 0.0% |
2019 Q4 | -1.08 Million EUR | 0.0% |
2018 Q2 | 1.00 EUR | 0.0% |
2018 FY | - EUR | -100.0% |
2018 Q4 | - EUR | 0.0% |
2017 FY | 2.00 EUR | 200324867.16% |
2017 Q4 | 2.00 EUR | 0.0% |
2017 Q2 | - EUR | 0.0% |
2016 Q2 | - EUR | 0.0% |
2016 Q4 | - EUR | 0.0% |
2016 FY | - EUR | -100.0% |
2015 FY | 1.00 EUR | -100.0% |
2015 Q2 | 492.38 Thousand EUR | 0.0% |
2015 Q4 | 1.00 EUR | 0.0% |
2014 Q1 | 1.00 EUR | -100.0% |
2014 Q4 | 111.87 Thousand EUR | 0.0% |
2014 Q2 | 1.00 EUR | 0.0% |
2014 FY | 111.87 Thousand EUR | -23.57% |
2013 Q4 | 146.37 Thousand EUR | 0.0% |
2013 FY | 146.37 Thousand EUR | 30.21% |
2012 FY | 112.41 Thousand EUR | 70.07% |
2011 FY | 66.1 Thousand EUR | 10424550.74% |
2010 FY | 0.63 EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Nicox S.A. | - EUR | -Infinity% |
European Medical Solutions | 14.35 Million EUR | -1858.001% |
FERMENTALG | 6.8 Million EUR | -4030.617% |
BioSenic S.A. | - EUR | -Infinity% |
Celyad Oncology SA | 1.26 Million EUR | -22211.886% |
Hyloris Pharmaceuticals SA | 1.00 EUR | -28112976800.0% |
Onward Medical N.V. | 936 Thousand EUR | -29935.232% |
Oxurion NV | 128 Thousand EUR | -219532.632% |
PHAXIAM Therapeutics S.A. | 671 Thousand EUR | -41797.134% |
Financière de Tubize SA | - EUR | -Infinity% |
UCB SA | 1.03 Billion EUR | 72.732% |